Effects of antifungal agents and gamma interferon on macrophage cytotoxicity for fungi and tumor cells.
about
Improvement of amphotericin B activity during experimental cryptococcosis by incorporation into specific immunoliposomesRoles of endogenous gamma interferon and macrophage microbicidal mechanisms in host response to chemotherapy in experimental visceral leishmaniasisPentoxifylline modulates activation of human neutrophils by amphotericin B in vitro.Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.Lipid complexing decreases amphotericin B inflammatory activation of human neutrophils compared with that of a desoxycholate-suspended preparation of amphotericin B (Fungizone).Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B.Characteristics of invasive candidiasis in gamma interferon- and interleukin-4-deficient mice: role of macrophages in host defense against Candida albicans.Mouse-human immunoglobulin G1 chimeric antibodies with activities against Cryptococcus neoformans.Phenotypic and functional characterization of human lymphocytes activated by interleukin-2 to directly inhibit growth of Cryptococcus neoformans in vitroA new azole derivative of 1,4-benzothiazine increases the antifungal mechanisms of natural effector cellsReduction of no synthase expression and tumor necrosis factor alpha production in macrophages by amphotericin B lipid carriers.Antifungal pharmacodynamics: review of the literature and clinical applications.Cryptococcal Meningitis in HIV-Infected Patients.In vivo immune responses to Candida albicans modified by treatment with recombinant murine gamma interferon.Monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan enhance fluconazole efficacy.Anticryptococcal effect of amphotericin B is mediated through macrophage production of nitric oxide.Antibodies to Cryptococcus neoformans glucuronoxylomannan enhance antifungal activity of murine macrophagesEnhancement of macrophage candidacidal activity by interferon-gamma. Increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannose receptors.Enhancement of a TH1 immune response in amphotericin B-treated mucocutaneous leishmaniasisCandida mannan: chemistry, suppression of cell-mediated immunity, and possible mechanisms of action.Modulation of interactions of Candida albicans and endothelial cells by fluconazole and amphotericin B.Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial.Poly(I.C)-induced interferons enhance susceptibility of SCID mice to systemic candidiasis.In vivo activation of macrophage oxidative burst activity by cytokines and amphotericin B.Pharmacotherapy of cryptococcosis.Current concepts in cryptococcosis.Cryptococcal Disease in HIV-Infected Children.Accumulation of amphotericin B in human macrophages enhances activity against Aspergillus fumigatus conidia: quantification of conidial kill at the single-cell levelEnhancement of nitric oxide synthesis by macrophages represents an additional mechanism of action for amphotericin B.Uptake of itraconazole by alveolar macrophages.Augmentation of murine tumor necrosis factor production by amphotericin B in vitro and in vivo.Enhancement of macrophage superoxide anion production by amphotericin B.Mechanism for candidacidal activity in macrophages activated by recombinant gamma interferon.Cerebrospinal fluid macrophage response to experimental cryptococcal meningitis: relationship between in vivo and in vitro measurements of cytotoxicity.Synergy of itraconazole with macrophages in killing Blastomyces dermatitidis.Novel aspect of amphotericin B action: accumulation in human monocytes potentiates killing of phagocytosed Candida albicans.Effect of macrophage colony-stimulating factor on anticryptococcal activity of bronchoalveolar macrophages: synergy with fluconazole for killing.Effect of in vivo macrophage colony-stimulating factor on fungistasis of bronchoalveolar and peritoneal macrophages against Cryptococcus neoformans.Cytokines in the treatment of fungal infections.Immunomodulating activity of antifungal drugs.
P2860
Q28328605-471B7AF1-F2ED-458F-920B-371D4C7419FDQ28343835-01D3792E-0997-4138-AABC-F8C03E6FBBE2Q30311275-67BAA28D-06CA-4DBA-9BCF-B0C4EC1C1824Q30424017-D7FE34E3-C3A6-4FC9-BDFF-0274D5325B94Q30436889-9860F3B9-E2DC-4021-AA7A-5D03F340A404Q33751411-5DBC8313-E874-4C78-A64E-54982767046BQ33752636-A7755FD0-E500-4DFD-BB95-BA7B7E470F2AQ33754371-6F9F38BF-3E84-4A7A-921C-2A4453ECA66FQ33895762-3B7BBF74-EEE1-4197-B50C-3C0972CC191BQ33977602-51B99AC0-A4F9-4279-A032-0371B1503E44Q33981451-42A06EE1-5502-4A9F-A60B-2523650EE20EQ34083129-4B028038-4F2E-4FC0-9DDE-227CB05FE180Q34092284-3643B4FA-5271-4099-A52A-3DF46F197E1FQ35097210-F5F967FC-35BD-4378-B515-7250E8688B2BQ35115708-FEF87905-BCEB-4E64-A016-5EB80E243B82Q35126226-52CBA98C-6C39-42A6-8CBF-EA477D500256Q35386000-E441705E-21BD-4DBA-87B2-D35A334D8073Q35610791-CAE4D04C-0D93-4F66-B79A-E517DBF50F1FQ35868724-3BFDB7C0-B453-4FFB-B56A-A4E98FB31A15Q36636840-9E0DB04E-5A45-4E5E-8932-B0D6C17E45FBQ36757860-D347D2F5-9955-4263-A7BC-A3CE0396528DQ36806209-4794DA80-280E-429D-9563-5B690EE64285Q36969872-4CD4F9AF-96C0-4343-8224-8FD39269B6F4Q36980949-E9E81B62-E818-47E1-A0D4-B9C10B856238Q37587230-E79F2F4D-10CF-4B53-8D33-394F63FEA61DQ38229538-0A550845-6C0A-4911-87EA-6B90BE70FE49Q38904619-036ABAA1-3CCA-48BD-ACF0-6F603379EE84Q39559102-F3F7BA69-C447-46C4-A1E2-F499224E697BQ39784797-145A4316-B571-4954-BA13-98BCA97D792CQ39865724-F8FB091E-C493-4E46-86E1-FB84841C1C00Q39881991-B4DA1779-0BED-47A7-A61B-3C82AF87AAE6Q40086453-66E52761-6F25-4028-97B2-2B54015B22CDQ40149867-AB3EA659-8581-49A2-A712-F2CDE5FB706DQ40157847-27DADD38-2B5A-4576-8BED-FC0D0D3D46D8Q40284545-362450DF-FE35-4C1A-8AB9-2C3DE8FFD393Q40284723-70B0D0C0-B170-41EB-82D0-33E313506706Q40286412-67CA26A6-6E59-4601-9EBB-852AE4C9109DQ40286418-B45973DD-8CC6-40E7-BFA5-2037A761EC5AQ40598683-F518B2E4-CA29-4BF7-8795-A95676880CD0Q40841490-2B801F5F-DA9C-48C4-AC68-76375E1D6AAF
P2860
Effects of antifungal agents and gamma interferon on macrophage cytotoxicity for fungi and tumor cells.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh-hant
name
Effects of antifungal agents a ...... ity for fungi and tumor cells.
@en
Effects of antifungal agents a ...... ity for fungi and tumor cells.
@nl
type
label
Effects of antifungal agents a ...... ity for fungi and tumor cells.
@en
Effects of antifungal agents a ...... ity for fungi and tumor cells.
@nl
prefLabel
Effects of antifungal agents a ...... ity for fungi and tumor cells.
@en
Effects of antifungal agents a ...... ity for fungi and tumor cells.
@nl
P2093
P356
P1476
Effects of antifungal agents a ...... ity for fungi and tumor cells.
@en
P2093
P304
P356
10.1093/INFDIS/156.2.316
P407
P577
1987-08-01T00:00:00Z